Role of Antibodies Against Glutamate Receptors and Double Stranded DNA in Epilepsy Patients

Hadassah Medical Center

Status: Unknown

Conditions: Epilepsy

Study type: Observational

Funder types: Other

Identifiers

NCT00317668

autoimmunepi-HMO-CTIL

Details and patient eligibility

About

The investigators will check the serum of epilepsy patients for antibodies against glutamate receptors and double stranded DNA. They will characterise the patients (by the kind of epilepsy, autoimmune disease comorbidity, and cognitive profile).

Enrollment: 250 estimated patients

Sex: All

Ages: 18 to 90 years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• 120 epilepsy patients from the epilepsy clinic and Emergency Room (ER)
• Controls: 100 patients with other neurological diseases and no epilepsy; and 30 healthy volunteers.